Venture Capital Trusts raised £731 million in the 2018-19 tax year, overtaking the year before – despite a very different shape to the year’s fundraising.Wealth Club has tracked new VCT share offers throughout the tax year; ...
There are three things that could help experienced investors save tax right at the beginning of the new tax year.Wealth Club is the only service that allows you to apply for all these offers online. Please ...
If there was an accolade for the most dramatic VCT makeover, the Foresight 4 VCT could surely be a strong contender.It started its life as an amalgamation of several previously underperforming VCTs run by other providers, ...
If you walked down any UK high street 30 years ago there would hardly have been a gym in sight. Today every town will have at least one.The next concept taking hold is the boutique fitness ...
The UK is an ideas factory. And it’s slowly but surely getting better at turning great ideas into commercial successes. Many of these ideas have come out of university research projects.Indeed, Cambridge University has spun out ...
You often hear this: people start a new business to “scratch an itch”. This is certainly true in my case. I had recently left Hargreaves Lansdown where I was a director and shareholder. Having sold some ...
Good fund managers are choosy when it comes to investment selection. However, it’s probably fair to describe Ian Warwick, Managing Partner of Deepbridge, as downright fussy. So, what are the requirements?Firstly, to be considered for the ...
In 2016/17 nearly £1.8 billion was invested under EIS. Demand from investors is set to rise further, as tax changes and pension restrictions continue to bite for wealthy investors. What is EIS?The EIS (Enterprise Investment Scheme) ...
Alex Chesterman OBE is one of the UK’s most successful serial entrepreneurs. He built his success by turning existing stale markets on their heads. In 2003, he disrupted the DVD rental market with the launch of ...
As many as 42% of paediatric clinical trials end up in failure and inconclusive results. Look at it another way: nearly half of the billions of dollars big pharma companies invest in clinical trials on children ...
